Skip To Main Content
Nanci Yumi Utida on Muck Rack

Nanci Yumi Utida

As seen in: Nature, Value in Health Journal, GaBI Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nanci Yumi

Contact Nanci Yumi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Economic feasibility of ‘Pay One Price’: an analysis of three biosimilar molecules with different prices and indicated for rheumatoid arthritis in a medium size HMO

|
By Francisco Prota, Nanci Yumi Utida
| GaBI Journal Verified
Published on 18 May 2026 Generics and Biosimilars Initiative Journal (GaBI Journal). 2026;15(2). DOI: 10.5639/gabij.2026.1502.
Open in Who Shared Issue with article?

EE526 REAL-WORLD BUDGET IMPACT ANALYSIS OF BIOSIMILAR ADOPTION IN A MEDIUM-SIZED BRAZILIAN HEALTH MAINTENANCE ORGANIZATION (HMO)

|
By São Paulo, Ricardo Beneti, Nanci Yumi Utida, Ricardo Bueno, Fernando Senra, Camila Cola
| Value in Health Journal Verified
Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
Open in Who Shared View Duplicates (117) Issue with article?

Cross-cancer survival prediction using machine learning models

|
By Lucas Cardoso, Tatiana Natasha Toporcov, Maria Paula Curado, Gisele Aparecida Fernandes, Adeylson Guimarães Ribeiro, Bryan Chin, Vanderlei Cunha Parro, Jones Eduardo Egydio, Nanci Yumi Utida
| Nature Verified
Abstract Among the many challenges faced by healthcare systems, cancer remains one of the most urgent. This makes the application of artificial intelligence a critical tool for enhancing early detection and optimizing treatment strategies, especially given the growing volume of patient data being collected. In this study, machine learning models trained on data for a specific type of cancer were employed to predict three-year survival after diagnosis for other cancer types.
Open in Who Shared Issue with article?
See all 3 articles